OpenFederal grantOpen to for-profit businessesPAR-28-056

Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional)

National Institutes of HealthCloses Nov 5, 2029(1119 days left)Up to $600,000

Does this fit your business?

This is an NIH/NCI research grant for teams developing biomarkers, imaging tools, and machine-learning methods to detect pancreatic cancer early, including building a shared biospecimen biorepository. It fits research-heavy organizations in healthcare and biotech; retail, finance, transportation, and other unrelated businesses should not bother applying. The largest award is $600,000, no cost sharing is required, and applications are due November 5, 2029.

Best for
Research teams studying early detection of pancreatic cancer, Small biotech or for-profit companies developing biomarkers or diagnostics, Universities and medical centers running clinical studies, Nonprofits and tribal organizations with biomedical research capacity
Not for
Businesses outside biomedical research or diagnostics, Organizations with no research or clinical study capability, Foreign entities or U.S. organizations with foreign components
Estimated fit by industry, best first
IndustryEstimated fit
Healthcare & BiotechMatches your industry (clinical)
68
Good Match
Construction & InfrastructureMatches your industry (building)
54
Possible Match
Education & TrainingMatches your industry (learning)
54
Possible Match
Energy & Clean TechLimit: Nothing in this notice points to energy & clean tech
54
Possible Match
Environment & ConservationLimit: Nothing in this notice points to environment & conservation
54
Possible Match
Technology & SoftwareLimit: Nothing in this notice points to technology & software
54
Possible Match
Show all 15 industries
Estimated fit by industry, best first
IndustryEstimated fit
Food & BeverageLimit: Nothing in this notice points to food & beverage
52
Possible Match
Agriculture & FarmingLimit: Nothing in this notice points to agriculture & farming
51
Possible Match
Arts & CultureLimit: Nothing in this notice points to arts & culture
51
Possible Match
Housing & Real EstateLimit: Nothing in this notice points to housing & real estate
51
Possible Match
Social Services & NonprofitLimit: Nothing in this notice points to social services & nonprofit
51
Possible Match
ManufacturingLimit: Nothing in this notice points to manufacturing
50
Possible Match
Retail & E-CommerceLimit: Nothing in this notice points to retail & e-commerce
50
Possible Match
Finance & BankingLimit: Nothing in this notice points to finance & banking
49
Possible Match
Transportation & LogisticsLimit: Nothing in this notice points to transportation & logistics
49
Possible Match

These are our matcher’s estimates for a typical business in each industry. A real match depends on your size, your state and what you need the money for — check your own fit.

What this funds

Money can be used for
Research, Biomarker development, Biorepository, Machine learning, Clinical studies
Who can apply
Small businesses, For-profit companies, Nonprofits, State and local governments, Tribal governments and organizations, Colleges and universities, Other applicants (see eligibility)
Award range
Up to $600,000

Questions about this grant

When is the application deadline?
November 5, 2029.
How much funding can an applicant receive?
The largest award listed is $600,000. No other award amounts are published.
Who can apply for this grant?
Eligible applicants include small businesses, for-profit organizations, nonprofits (with or without 501(c)(3) status), state, local, county, and tribal governments, public housing authorities, independent school districts, and public or private institutions of higher education. Foreign organizations and foreign components of U.S. organizations are not eligible.
Can a sole proprietor or single-member LLC apply?
The notice does not say. Small businesses are eligible, but whether a sole proprietor or single-member LLC qualifies is not published in the facts provided.
Can a nonprofit apply?
Yes. Both nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status are listed as eligible, other than institutions of higher education.

Summary

NCI funds Research Units within the Pancreatic Cancer Detection Consortium to develop and validate molecular, imaging, and computational biomarkers for early detection of pancreatic cancer and its precursor lesions, and to build a shared biospecimen biorepository. Eligible applicants include small businesses, for-profit organizations, nonprofits, state/local/tribal governments, public housing and

About this grant

Through this Notice of Funding Opportunity (NOFO), NCI solicits applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify patients who are at high risk of progression to cancer. The PCDC will continue to address one of the four research priorities identified in the NCI's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma (PDAC). The PCDC will support research for the development and testing of new molecular and imaging biomarkers for detecting PDAC early and for identifying patients at high risk of PDAC (because of genetic factors, family history and/or the presence of precursor lesions) who could be candidates for early intervention. The PCDC-RUs will consist of multi-disciplinary teams and will undertake studies to: identify and test biomarkers measurable in bodily fluids for early detection of PDAC and/or its precursor lesions; develop molecular- and/or imaging-based markers of pancreatic cysts and determine which lesions are likely to progress to cancer; develop molecular- and/or imaging-based approaches for screening populations at high risk of PDAC; use machine learning and computational approaches towards biomarker discovery and/or validation; and conduct biomarker validation studies. The PCDC-RUs will also collect longitudinal biospecimens for building a biorepository. Each PCDC-RU is expected to participate in collaborative activities with other PCDC-RUs and share ideas, biospecimens, and data within the Consortium.

Who can apply

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Topics and uses of funds

Topics

  • Health
  • Science
  • Cancer research
  • Biomarkers
  • Early detection

Program contact

National Institutes of Healthncipcdc@nih.gov301-402-2541

Related grants

Open opportunities funding similar work, from the same funder or in the same place.

All grantsGrants by stateGrants by industry